Schonfeld Strategic Advisors’s Amgen AMGN Stock Holding History

Schonfeld Strategic Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-55,000	Closed	-$17.7M	–	1975
2024 Q3	$17.7M	Buy	+55,000	New	+$18M	0.12%	168

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Schonfeld Strategic Advisors's AMGN Position: Q1 2026 in Review

Schonfeld Strategic Advisors sold out of Amgen (AMGN) in Q1 2026, closing a stake of 36,625 shares — an estimated $13.1M sold.

Schonfeld Strategic Advisors first reported a position in AMGN in Q3 2016 and held it in 26 quarters. The position peaked at $32.1M in Q2 2022. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Schonfeld Strategic Advisors reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
Schonfeld Strategic Advisors sold 36,625 Amgen shares in Q1 2026, an estimated $13.1M.
Schonfeld Strategic Advisors first reported a position in Amgen in Q3 2016 and held it in 26 quarters.
Schonfeld Strategic Advisors's Amgen position peaked at $32.1M in Q2 2022.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.